Procter & Gamble Form 4: option exercise 13,779 shares; sale 1,704
Rhea-AI Filing Summary
Matthew W. Janzaruk, SVP and Chief Accounting Officer of Procter & Gamble Co (PG), reported transactions dated 10/01/2025. He exercised_stock_options to acquire 13,779 shares (stock option exercise price $153.18) and directly holds those 13,779 shares following the exercise. The Form 4 also shows a sale of 1,703.9031 shares on the same date and reports 3,293.5342 shares beneficially owned indirectly via a retirement plan trustee after an adjustment through 9/30/2025. The filing was signed by an attorney-in-fact on 10/02/2025. The report is an insider disclosure of option exercise, a small open-market sale, and an adjustment to retirement-plan holdings; it contains transaction dates, amounts, and the exercise price but no cash proceeds or reasons for the transactions.
Positive
- Exercised 13,779 options into 13,779 direct shares
- Filing discloses exact exercise price of $153.18
Negative
- Sale of 1,703.9031 common shares on 10/01/2025
Insights
Insider exercised options and sold a portion of shares on 10/01/2025.
The filing shows a stock option exercise converting 13,779 options into 13,779 shares at an exercise price of $153.18. That action increased the reporting person's direct share count by 13,779.
The report also records a sale of 1,703.9031 shares and an indirect holding of 3,293.5342 shares via a retirement plan trustee after an adjustment through 9/30/2025. These are standard Section 16 disclosures showing personal liquidity action and plan-account adjustments; the filing contains no proceeds or hedging arrangements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 13,779 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- [object Object]